Tonix Pharmaceuticals Holding Corp.·4

Feb 24, 6:36 PM ET

MORRIS JESSICA EDGAR 4

4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 24, 2023

Insider Transaction Report

Form 4
Period: 2023-02-23
MORRIS JESSICA EDGAR
Chief Operating Officer
Transactions
  • Award

    Stock Option

    2023-02-23+207,500207,500 total
    Exercise: $0.91From: 2024-02-23Exp: 2033-02-23Common Stock (207,500 underlying)
  • Award

    Stock Option

    2023-02-23+207,500207,500 total
    Exercise: $0.73From: 2024-02-23Exp: 2033-02-23Common Stock (207,500 underlying)
Footnotes (2)
  • [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Documents

1 file
  • 4
    ownership.xmlPrimary

    BENEFICIAL OWNERSHIP